Cabinet Becker Associs patent opposition analysis

The comprehensive analysis of Cabinet Becker Associs opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Cabinet Becker Associs

Patent NumberTitleApplicantOpposition DateOpposition Company
Nemolizumab In The Treatment Of Atopic Dermatitis With Moderate To Severe ExcoriationCHUGAI SEIYAKU KABUSHIKI KAISHAApr 30, 2026CABINET BECKER ASSOCIS
Method For In Vitro Production Of Hyaline Cartilage TissueVANARIXJul 16, 2025CABINET BECKER ASSOCIS
Process For Enzymatic Oil DegummingDSM ASSETSJul 8, 2025CABINET BECKER ASSOCIS
Probiotic BacteriaSKINBIOTHERAPEUTICSJan 28, 2022CABINET BECKER ASSOCIES
Reduced Salt Precipitation In Carbohydrate Containing Binder CompositionsJOHNS MANVILLEApr 3, 2018SAINT GOBAIN ISOVER
Curable Formaldehyde-Free Resin Dispersion And Improved Mineral Wool Products Produced TherewithURSA INSULATIONJan 16, 2018SAINT GOBAIN ISOVER

Top companies who are the clients of Cabinet Becker Associs